Global Plasma Therapeutics Market 2015-2019 with Baxter, CSL Behring, Grifols Therapeutics & Octapharma Dominating

News provided by

Sep 09, 2015, 10:10 ET

DUBLIN, Sept. 09, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/xm38pg/global_plasma) has announced the addition of the "Global Plasma Therapeutics Market 2015-2019" report to their offering.

The global plasma therapeutics market to grow at a CAGR of 12.10% over the period 2014-2019.

The report covers the present scenario and the growth prospects of the global plasma therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI.

The report, Global Plasma Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global plasma therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Patient assistance programs for plasma therapeutics are boosting the growth of the market. Vendors nowadays provide co-pay assistance to individuals who purchase plasma therapeutics.

According to the report, IVIG is the largest segment of the plasma therapeutics market. IVIG is being increasingly used due to increases in the number of bleeding disorders, CIDP, and the global aging population. This has led to increased demand for IVIG therapeutics.

Further, the report states that the high cost of plasma therapeutics hinders market growth. Plasma protein therapies cost nearly four times more than other pharmaceutical medicines because of the use of expensive technologies in the manufacturing and processing of plasma-derived products.

Key vendors

- Baxter
- CSL Behring
- Grifols Therapeutics
- Octapharma

Other prominent vendors

- Abeona Therapeutics
- ADMA Biologics
- Amag Pharmaceuticals
- Antares Pharma
- BioDelivery Sciences
- Bio Products Laboratory
- Biota Pharmaceuticals
- Biotest Pharmaceuticals
- China Biologic Products
- Depomed
- Emergent BioSolutions
- Ethicon
- Flamel Technologies
- Kamada
- Kedrion
- King Pharmaceuticals
- Nektar Therapeutics
- OMRIX Biopharmaceuticals
- ProMetic Life Sciences
- Rockwell Medical
- The Medicines
- ZymoGenetics

For more information visit http://www.researchandmarkets.com/research/xm38pg/global_plasma